Key Events This Week
2 Mar: Stock opens with a sharp gap down amid market concerns
2 Mar: Downgrade to Strong Sell by MarketsMOJO due to weak financials and bearish technicals
4 Mar: Technical momentum shifts further bearish with deteriorating indicators
6 Mar: Week closes at Rs.699.45, down 3.31%

Aarti Pharmalabs Ltd Technical Momentum Shifts Amid Bearish Signals
2026-03-04 08:07:21Aarti Pharmalabs Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to a more pronounced bearish trend. Despite a recent weekly price gain, the stock’s overall technical profile and market performance suggest caution for investors amid weakening momentum and deteriorating technical grades.
Read full news article
Aarti Pharmalabs Ltd Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals
2026-03-03 09:03:36Aarti Pharmalabs Ltd has been downgraded from a Sell to a Strong Sell rating as of 2 March 2026, reflecting deteriorating fundamentals and bearish technical indicators. The downgrade follows a comprehensive reassessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals, signalling heightened caution for investors amid ongoing challenges in the pharmaceuticals sector.
Read full news article
Aarti Pharmalabs Ltd Opens with Significant Gap Down Amid Market Concerns
2026-03-02 13:34:37Aarti Pharmalabs Ltd commenced trading today with a pronounced gap down, opening at a price 7.31% lower than its previous close, reflecting heightened market apprehension. The stock’s weak start follows a series of mixed technical signals and a downgrade in its Mojo Grade, contributing to a cautious trading environment.
Read full news article
Aarti Pharmalabs Ltd is Rated Sell
2026-02-26 10:11:18Aarti Pharmalabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 January 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 26 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Aarti Pharmalabs Ltd is Rated Sell
2026-02-15 10:10:45Aarti Pharmalabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 February 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article







